$BMY Company News Not all pharmaceuticals are created

New Post Public Reply Private Reply Replies (0) Message Board

Jan 7, 2014 at 11:49 AM

$BMY Company News

Not all pharmaceuticals are created equal 12:40 p.m. Dec. 26, 2013 - The Trading Deck
FTSE 100 rises, shaking off retail data after Fed taper 12:06 p.m. Dec. 19, 2013 - Sara Sjolin
European stocks rally on Fed taper, rate views 12:00 p.m. Dec. 19, 2013 - Sara Sjolin
AstraZeneca to buy Bristol-Myers diabetes-JV stake 3:25 a.m. Dec. 19, 2013 - MarketWatch.com
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - Russ Britt
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
S&P, Dow hold tightly to record territory 10:36 a.m. Nov. 4, 2013 - Michael Ashbaugh
J.C. Penney, Bristol-Myers top S&P 500 6:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 3:58 p.m. Oct. 28, 2013 - Victor Reklaitis
Bristol-Myers shares jump on promising results for two new drugs 10:58 a.m. Oct. 28, 2013 - Russ Britt
Bristol-Myers Squibb leads S&P 500 gainers, up 5% 8:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 8:31 a.m. Oct. 28, 2013 - Victor Reklaitis
Bristol-Myers lifted to overweight: Morgan Stanley 7:16 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Drug-maker earnings come in ahead of views, but stocks aren't rewarded 10:45 a.m. Oct. 23, 2013 - Russ Britt
Stock futures retreat; Cat misses on earnings 7:42 a.m. Oct. 23, 2013 - William L. Watts
Bristol-Myers swings to profit; sales grow again 6:43 a.m. Oct. 23, 2013 - MarketWatch.com
Boeing, AT&T, Caterpillar are stocks to watch 4:31 a.m. Oct. 23, 2013 - Sue Chang
No shortcut to innovation 7:30 a.m. Oct. 2, 2013 - Mark Hulbert
A strong 2014 will take the S&P over 2,000 10:41 a.m. Sept. 24, 2013 - The Trading Deck

Is the Biotech Boom Over? 50 min ago - Barrons.com
The Twitterverse's Biotech Stock Picks for 2014 8:00 a.m. Today - TheStreet.com
Exelixis Has A Stellar Year Ahead 5:21 p.m. Jan. 6, 2014 - Seeking Alpha
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner 5:00 p.m. Jan. 3, 2014 - TheStreet.com
5 Stocks Improving Performance Of The Drugs Industry 12:03 p.m. Jan. 3, 2014 - TheStreet.com
Valeant Is Having a Healthy Run 6:30 a.m. Jan. 3, 2014 - TheStreet.com
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race 8:58 a.m. Jan. 2, 2014 - Seeking Alpha
Dividend Champions For January 2014 12:17 a.m. Jan. 2, 2014 - Seeking Alpha
The Top Five Drug Launches Of 2013 12:42 p.m. Dec. 31, 2013 - Investors Business Daily
Jazz, Valeant Join Drug Makers' Q4 Merger Rush 5:39 p.m. Dec. 30, 2013 - Investors Business Daily
Bristol-Myers' AstraZeneca Deal Is a Win 3:18 p.m. Dec. 30, 2013 - Barrons.com
Tuesday's Ex-Dividends To Watch: RCII, TMK, SYY, BMY 10:00 a.m. Dec. 30, 2013 - TheStreet.com
Getting The New Year Off To A Bad Start 11:10 a.m. Dec. 28, 2013 - Seeking Alpha
New Drugs Could Change Cancer Landscape In 2014 5:20 p.m. Dec. 27, 2013 - Investors Business Daily
3 Stocks Dragging In The Drugs Industry 12:03 p.m. Dec. 27, 2013 - TheStreet.com
5 Pharmaceutical Stocks to Buy Now 6:30 a.m. Dec. 27, 2013 - InvestorPlace.com
Cramer's 'Mad Money' Recap: Timing Is Everything 6:00 p.m. Dec. 26, 2013 - TheStreet.com
Genetic Technologies updates patent program, grants license 8:19 a.m. Dec. 24, 2013 - Seeking Alpha
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
Gilead Sciences And The Numbers Game 9:51 a.m. Dec. 23, 2013 - Seeking Alpha

Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan 8:00 a.m. Today - PR Newswire
Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2013 on January 24 3:15 p.m. Jan. 6, 2014 - BusinessWire
Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference 11:02 a.m. Jan. 6, 2014 - BusinessWire
Bristol-Myers Squibb to Take Part in Goldman Sachs Healthcare CEOs Unscripted Conference 2:29 p.m. Jan. 3, 2014 - BusinessWire
New Business Ventures, Quarterly Dividends, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, DENTSPLY, Pharmacyclics, and St. Jude Medical 8:00 a.m. Dec. 25, 2013 - PR Newswire
Fitch Revises Bristol-Myers Squibb's Rating Outlook to Negative; Affirms IDR at 'A-' 1:49 p.m. Dec. 23, 2013 - BusinessWire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Heineken N.V. to nominate Mr. Jean-Marc Huet as Supervisory Board member 2:01 a.m. Dec. 20, 2013 - Thomson Reuters ONE
FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE 5:01 p.m. Dec. 19, 2013 - BusinessWire
Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022 1:00 p.m. Dec. 19, 2013 - PR Newswire
The Novel Oral Anticoagulants Will Continue to Drive Growth in the Atrial Fibrillation Drug Market 11:00 a.m. Dec. 19, 2013 - PR Newswire
Bristol-Myers Squibb Announces Dividend Increase 3:34 a.m. Dec. 19, 2013 - BusinessWire
Bristol-Myers Squibb Continues Evolution to Specialty BioPharma Through Sale of Its Diabetes Business 2:56 a.m. Dec. 19, 2013 - BusinessWire
Critical Alerts For 21st Century Fox, Whole Foods Market, Rackspace, Vodafone, and Bristol-Myers Squibb Released By InvestorsObserver 9:31 a.m. Dec. 18, 2013 - PR Newswire
Bristol-Myers Squibb Foundation Awards $3.28 Million in Grants to Support Mental Health Needs of U.S. Military Service Members Returning from Afghanistan and Iraq 9:00 a.m. Dec. 17, 2013 - BusinessWire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
Clinical Trial Results, Share Repurchase Transactions, Stock Price Updates, Appointments, and Investments - Research Report on AbbVie, Express Scripts, Actavis, Bristol-Myers Squibb, and GSK 8:00 a.m. Dec. 13, 2013 - PR Newswire
FDA Advisory Committee Recommends the Investigational SGLT2 Inhibitor Dapagliflozin for the Treatment of Type 2 Diabetes in Adults 6:59 p.m. Dec. 12, 2013 - BusinessWire
RBCC and Therakine Initiate Phase II of Drug Delivery Development 5:00 a.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee Votes on Investigational Medicine Metreleptin 9:49 p.m. Dec. 11, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EDB Enhances Postgres with Horizontal Scaling Preview

EDB's Ambitious Move Into Seamless Data Growth Right out of Wilmington, Delaware, EnterpriseDB (EDB) is sowing the seeds for a seismic change in how enterprises juggle their data systems. With 86% of the top brass anticipating AI data systems becoming top-tier indispensable, the unveiling of EDB’s horizontal scaling for their Postgres AI Distributed is a tune you just...

Anguilla: Paradise for Safe, Solo Beach Escapes

A Safe Haven for Solo Adventurers You ever dream of escaping to a place where the world slows down and serenity reigns supreme? Somewhere you can kick back, soak up the sun, listen to the waves, and leave your worries behind? Well, folks, Tranquility Beach Anguilla fits that bill and then some. Why Anguilla Tops the List Let's talk about the accolades Anguilla has raked...

Oxford Bank Reports Strong Q3 Amid Challenges

Digging Into Oxford Bank's Q3 Numbers You ever wonder how a smaller banking outfit yet to become a household name manages to punch above its weight? Let's look at Oxford Bank Corporation's (OTCQX: OXBC) third-quarter antics, where dreams of better margins and loan growth dance, even as operational costs spike. Net Income Climbs Despite Rising Costs The headline here is...

Rockford Fosgate Elevates Marketing Maverick to Lead Role

Changing the Guard in High-Performance Audio Marketing Out of Arizona, we get a shake-up that feels like a no-brainer for anyone in the high-performance audio market. Rockford Fosgate decided to elevate Tammy Lowe to the Vice President of Marketing role, effective immediately. With nearly four decades under her belt at the sunny Tempe-based HQ, it's hard to argue with the...

QuidelOrtho's Podcast: AI & Informatics Elevate Labs

Navigating Lab Complexities with QuidelOrtho Who'd have thought a podcast could shake the beakers in a lab? QuidelOrtho Corporation (NASDAQ:QDEL) proves the digital discourse is worth tuning into if you're eyeing diagnostic innovations lately. Episode 62 of their Science Bytes podcast unravels how AI and informatics are shifting gears in laboratory landscapes. The folks...

City National Grows with New Inglewood Branch

Inglewood, the New Banking Frontier It's not every day you see a bank banking on Inglewood, so to speak. Yet here we are. City National Bank is setting up shop in this buzzing part of Los Angeles, and it's high time someone paid attention to this vibrant hub. With major players in sports, entertainment, healthcare, and even aerospace calling Inglewood home, there's plenty...

Anguilla Culinary Festival 2027: A Feast Beyond Food

A Culinary Quest in the Caribbean Imagine this: a culinary pilgrimage where the Caribbean’s essence is served on a plate. The Anguilla Culinary Experience (ACE), set for April 28 through May 2, 2027, isn't just about stretching waistbands. It’s about embracing the spirit and flavors of Anguilla, one of the world's cherished culinary hotspots. Cooking with Purpose ACE...

SeaWorld Rings in Holidays with All-New Festivities

Holiday Transformation at SeaWorld's Parks The holiday spirit isn't something you purchase—it’s an experience. And boy, SeaWorld seems to get this right. As the chill of late October settles in, SeaWorld parks across Orlando, San Diego, and San Antonio start dressing up for the holiday season, morphing into a spectacle of lights and festive joy. For anyone who’s...

Digital Science's Game-Changing Jenni AI Acquisition

A Strategic Move in the Research Sector When you're dealing with tech giants and their endless race to corner niche markets, it's the big moves that really catch one's attention. The latest acquisition on the block is Digital Science picking up Jenni AI, a platform trusted by over 8 million students and researchers scattered across 189 countries. Now, that's a hefty user...

BellRing Brands Lawsuit Hinges on Sales Misrepresentation

BellRing's Legal Tangle Deepens When it comes to drawing the line between having a good quarter and pulling the wool over investors' eyes, the latest lawsuit knotted up with BellRing Brands, Inc. (NYSE: BRBR) shows just how fine that line can be. This legal drama, filed on the not-so-distant date of January 22, 2026, isn't your garden-variety beef. We're talking...